http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105254695-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c52f84e914c11de7cf085d4b7becbb66
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 2015-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105254695-A
titleOfInvention Nucleoside phosphoramidate derivatives and their applications
abstract The present invention provides a nucleoside phosphoramidate derivative and its application, which is specifically a compound of formula I, or a pharmaceutically acceptable acid salt, solvate or hydrate thereof; wherein: R 1 is C 1-4 alkane R2 is an optionally substituted phenyl or naphthyl, and its substituents are selected from C 1-4 alkyl, C 1-4 alkoxy; R 3 is amino acid acyl or polypeptide acyl. The compound of the present invention can be used to prepare medicines for preventing or treating mammalian infectious diseases, especially for preparing medicines for preventing or treating hepatitis C, liver cirrhosis and liver cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019080724-A1
priorityDate 2014-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015266918-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014209983-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465914190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467556109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129280605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164083676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411319011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429997110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13089460

Total number of triples: 29.